Background. Little is known about the clinical impact on cardiovascular stability during intermittent haemodialysis (IHD) for acute kidney injury (AKI) of online monitoring devices that control blood volume (BV) and blood temperature in the intensive care unit (ICU) setting. We compared different dialysis treatment modalities with or without these new systems among critically ill patients requiring IHD. Methods. In a prospective single-centre three-arm randomized controlled trial, 600 dialysis sessions in 74 consecutive AKI critically ill patients were involved to assess intradialytic hypotension. Standard dialysis therapy with constant ultrafiltration (UF) rate, cool dialysate and high sodium conductivity (Treatment A) was compared to regimens with adjunctive interventions including BV control (Treatment B) and the combination of BV and active blood temperature control (Treatment C). Each dialysis session was randomly assigned to one of the three treatment arms and served as statistical unit. Results. Five hundred and seventy-two dialysis sessions were analysed (188, 190 and 194 in Treatments A, B and C, respectively). Hypotension occurred in 16.6% treatments, with similar rates among the arms. Haemodynamic parameters and dialysis-related complications did not differ between therapies. Based on generalized estimating equation adjusted to dialysate sodium conductivity, higher Sequential Organ Failure Assessment the day of dialysis session, the need for vasopressors and lower systolic blood pressure at the onset of the session were identified as independent predictors of hypotensive episodes, whereas regimens containing the new online monitors were not. Conclusions. These results suggest that both actively controlled body temperature and UF profiled by online monitoring systems have no significant impact on the incidence of intradialytic hypotension in the ICU setting. Further research is needed before the use of these new sophisticated automatic methods can be applied routinely to the ICU setting.
Introduction
In critically ill patients with acute kidney injury (AKI) requiring renal replacement therapy (RRT), one of the most common and severe complications related to intermittent haemodialysis (IHD) is symptomatic hypotension [1] . Despite the optimization of practice guidelines including cool dialysate and high dialysate sodium concentration in the intensive care unit (ICU) setting [2, 3] , from 20 to 50% of dialysis sessions remain affected by this severe symptom which is associated with increased morbidity. The origin of intradialytic hypotension is multifactorial, depending both on factors related to the patient and on the dialysis modalities.
Some new devices based on the concept of online monitoring and automatic biofeedback control [4] [5] [6] for intradialytic blood volume (BV) [7, 8] and blood temperature [9, 10] changes have been widely used in recent years to improve haemodynamic stability in patients undergoing chronic renal disease dialysis. For example, the biofeedback approach for BV measurement is based on the real-time and repeated measurement of the haematocrit coming from the blood in order to control and modulate this variable gradually and smoothly along a pre-defined trajectory toward a pre-defined target. The same concept is used to control blood temperature. Thus, the automatic biofeedback control may help facilitate cardiovascular reactivity and enhance plasma refilling from the interstitial compartment, maintain thermal balance and prevent heat accumulation, thus helping to improve haemodynamic tolerance.
In the ICU setting, the population differs from chronic dialysis patients and specific factors may interact with vascular stability [1] . Although the combination of actively controlled body temperature with profiled ultrafiltration (UF) by online monitoring systems is promising [11] , their efficiency remains, however, unknown in AKI patients treated with IHD.
We hypothesized that the use of new online monitoring systems could reduce the incidence of symptomatic hypotension during dialysis sessions in critically ill patients with AKI requiring RRT. Therefore, we compared the risks and benefits of haemodialysis protocols either with BV control or with both BV and blood temperature control to those of our standard dialysis therapy with cool dialysate and high sodium conductivity. Our primary outcome was intradialytic hypotension.
Materials and methods

Study design, setting and randomization
The haemodialysis tolerance (HEMOTOL) study was a single-blind single-centre randomized controlled trial conducted in a 22-bed medical ICU and comparing a standard IHD protocol using cooled and high sodium dialysate and either BV-or BV-and blood temperature-controlled haemodialysis. After verification of patient eligibility, each dialysis session of each individual patient was randomized to a treatment group by a random-treatment letter generator. Randomization was performed centrally by permuted blocks of six, and concealed assignment was provided in sealed envelopes in a 1:1:1 ratio. The allocated groups were Treatment A ('standard' therapy), Treatment B (BV-controlled haemodialysis) and Treatment C (BV-and blood temperature-controlled haemodialysis). The patients were unaware of the treatment assignment per session. The study was approved by the ethics committee at the Côte de Nacre University Hospital, Caen, France. Written informed consent was obtained from the patients or next of kin at the time of enrolment into the trial.
Study population
All critically ill adults ( ≥ 18 years) with AKI requiring IHD as the first line of RRT in the unit were eligible for inclusion. AKI was defined according to the RIFLE (Risk, Injury, Failure, Loss and End-stage kidney disease) classification [12] . Only patients who underwent their first dialysis session for AKI in the ICU were considered. The exclusion criteria only included patients with end-stage renal disease, patients for whom RRT was first initiated with continuous veno-venous haemofiltration (n = 18 representing 18% of patients treated by RRT during the study period) were not eligible for the study and AKI dialysis sessions performed with an a priori intention for no UF.
Study protocol
The standard therapy used bicarbonate treatment with a constant UF rate and constant dialysate conductivity. In the BV-controlled haemodialysis therapy, IHD was performed with the Blood Volume Monitor (BVM®) (Fresenius Medical Care, France), which provides online monitoring of the relative BV (RBV), and individualized BV-dependent feedback control of the UF during the haemodialysis treatment. Briefly, the BVM® control is a linear proportional control that deals with a minimum RBV pre-defined each session of dialysis by the physician. The monitored parameter is the BV reduction, and a defined algorithm modulates and profiles UF according to the relation of the actual BV to the minimum RBV. UF is calculated with the following equation:
where the reduction factor is a coefficient between 0 (when minimum RBV is reached) and 1 (when the RBV is more than halfway the distance between the minimum RBV and 100%) determined according to the current RBV. Thus, in the BVM® algorithm, a mean and a maximum UF (from 1.5-to 2-times the ratio between the remaining UF and the remaining time), and the minimum admitted RBV are prescribed each session of dialysis and left to the discretion of the attending physician. The minimum UF was set to 100 mL/h. In the BV and blood temperature-controlled haemodialysis therapy, the T-control mode was added to the online BV monitoring. The Blood Temperature Management (BTM®) device (Fresenius Medical Care) permits control of the intradialytic body temperature by a physiological feedback control system. In the study protocol, the body temperature change rate during the session was set to 0.0°C/h to maintain isothermic cool dialysis.
Treatment characteristics
In patients with AKI, department protocol for RRT initiation and management followed standard recommendations to correct metabolic Online monitoring dialysis in ICUderangements and reduce fluid overload [2, 13, 14] . All patients had a 13F dual lumen polyurethane dialysis catheter (Hemoaccess®, Hospal, France) placed in a central vein (femoral or internal jugular access with 25 and 16 cm catheter lengths, respectively). All dialysis sessions were performed with a Fresenius 4008S haemodialysis monitor (Fresenius Medical Care) and the same type of synthetic membrane (FX 8; Fresenius Medical Care). To achieve optimal intradialytic haemodynamic tolerance [3] , standard dialysis therapy was performed with a bicarbonate-based buffer (32 mmol/L), a mildly hypothermic dialysate at a baseline dialysate temperature 1°C below body temperature (recorded from a distal esophageal thermometer) and a high dialysate sodium concentration to ensure a positive [dialysate − plasma] sodium gradient at the start of each session. The attending physician defined both the sodium conductivity and the duration of the dialysis session, but the latter was expected to be > 4 h. Dialysate enriched in potassium (2-3 mmol/L) and calcium (1.75 mmol/L) was systematically used. The dialysate flow rate was set at 500 mL/min. The blood pump speed was set at 200-250 mL/min and was then adjusted by nurses to maintain a venous pressure < 200 mmHg and an arterial pressure higher than −200 mmHg. Anticoagulation was performed routinely with low-molecular-weight heparin for each session.
The dialysis monitor was equipped with an Online Clearance Monitoring module for automatic and non-invasive measurement of ionic dialysance (ID). Independently of the weekly number of dialysis sessions, we chose to prescribe a Kt/V delivered from ID (Kt/V ID ) target of 1.2 per session following the National Kidney Foundation-Kidney Disease Outcome Quality Initiative (NKF-K/DOQI) guidelines [15] . For Kt/V ID , the volume of the distribution (V) of urea was calculated during each session with the estimated dry body weight of the patient. No other change in the management of the dialysed patients was implemented in our ICU during the study period.
Outcome variables
The primary outcome was symptomatic intradialytic hypotension [defined, in the absence of a generally accepted definition, as systolic blood pressure (SBP) < 90 mmHg] justifying therapeutic interventions (fluid administration, vasopressor introduction or a 25% increased dose of vasopressor to maintain adequate blood pressure). Intradialytic hypotension was defined as a dialysis session with at least one hypotension event.
The secondary outcomes were the following: (i) intradialytic cardiac arrhythmia defined as a sudden increase in heart rate > 125 beats/min or a decrease < 60 beats/min, atrial fibrillation and ventricular tachycardia or fibrillation and (ii) dialysis-related complications such as catheter dysfunction, filter clotting and discontinuation of IHD. Catheter dysfunction was defined as an inability to attain an adequate blood flow, requiring either line reversal or catheter replacement.
Data collection
Demographic and clinical data were collected at ICU admission. To assess the severity of the acute illness, the Simplified Acute Physiology Score II [16] , the initial Sequential Organ Failure Assessment (SOFA) score [17] and the need for organ support such as vasopressors and mechanical ventilation were determined within 24 h following ICU admission. SOFA score was also recorded daily during ICU stay. Data regarding IHD were recorded over the course of treatment during the ICU stay.
Power and statistical analysis
To detect a relative reduction of 40% in the intradialytic hypotension rate (i.e. from 30 to 18%) with 80% power and a two-sided α-level < 0.05, a sample size estimate of 195 dialysis sessions was required by each arm. The primary analysis was performed using the intention-to-treat (ITT) approach, in which dialysis sessions with missing data for the primary end point were excluded. The statistical unit was the dialysis session. No interim analysis was planned.
Qualitative and quantitative variables were compared using the chisquare test and the Kruskal-Wallis test, respectively. A univariate analysis was conducted to assess treatment protocol effect on intradialytic hypotension. A single-variable logistic regression model that involved generalized estimating equations (GEE) to account for repeated measures within patients was used [18] . To identify the set of independent factors associated with intradialytic hypotension, a multivariate analysis was also performed using the concept of the GEE model for binary outcomes. In the model, the outcome variable (intradialytic hypotension) was analysed as the dependent variable and treatment modality was the independent categorical variable, adjusting for variables related to the patients and dialysis modalities. Analysis of variance for repeated measures was used to determine whether haemodynamic parameters changed over dialysis sessions within different dialysis regimens, and differences in the means [95% confidence interval (CI)] among groups at each time of dialysis sessions were also tested by pairwise comparisons using the Student's t-test. All analyses were performed using SAS statistical software, version 9.1 (SAS Institute, Cary, NC). A P-value < 0.05 was considered to be significant.
Results
Study population and baseline characteristics of dialysis session
From November 2008 to January 2010, 785 patients were admitted to the ICU, and 83 patients had an indication for RRT. Of these, 9 met the exclusion criteria, leaving 74 patients for inclusion into the study and dialysis session randomization (Figure 1 ). The baseline characteristics of the 74 consecutive AKI patients included in the study are given in Table 1 . The cause of AKI was acute tubular necrosis in 88% of the cases, and haemodialysis was started for the F-RIFLE class of AKI in all but four patients. Figure 1 shows the dialysis session inclusion process for the HEMOTOL study. Among the 600 dialysis sessions randomly assigned to one treatment, 28 dialysis sessions (12, 10 and 6 dialysis sessions by treatment arm, respectively; P = 0.35) were subsequently censored from the ITT analysis due to intradialytic blood pressure missing data. Thus, 572 treatments (188 performed with Treatment A in 54 patients, 190 with Treatment B in 59 patients and 194 with Treatment C in 56 patients) were analysed for the primary outcome. Among the 74 patients, 43 (58%) were randomly assigned to at least one of each dialysis strategy during their ICU stay. The baseline dialysis treatment characteristics were similar in the three groups except for variables related to the tested interventions. First, the median body temperature change during the dialysis treatment was lower in the arm that underwent active control of body temperature compared to the arms using thermoneutral therapy (P = 0.01). Second, the median maximum UF rate was lower in the standard therapy arm (P < 0.0001) ( Table 2) .
Primary outcome
The rates of intradialytic hypotension in the intervention arms in which 'standard haemodialysis' was combined with either BV control or BV and blood temperature control were 17.4 and 15.0%, respectively, as compared with the rate of 17% observed in the control arm, in which standard haemodialysis was performed alone. There was no difference in the hypotension rate achieved using standard or intervention therapy in ITT analysis (Figure 2 ). Jugular and femoral access were 40 and 60%, respectively, in each group. The number of hypotension episodes in the dialysis session using a dialysis catheter placed in the jugular or femoral vein were 13/76 and 19/112 in Treatment A, 17/77 and 16/113 in Treatment B and 15/79 and 15/115 in Treatment C, respectively. No statistical difference was observed between both the vascular access sites among groups. In addition, based on a univariate analysis through the use of GEE, no effect of each new intervention was detected [Treatment B versus A: odds ratio (OR), 0.99; 95% CI, 0.63-1.97; Treatment C versus A: OR, 0.83; 95% CI, 0.55-1.29]. After adjustments for covariates and within patient correlation by GEE, no effect was found between intradialytic hypotension and the treatment modalities (Table 3 ). In this model, a higher SOFA score at the start of the dialysis session, a lower SBP and the need for vasopressors at the beginning of the dialysis session were identified as independent risk factors for intradialytic hypotension, whereas lower dialysate sodium conductivity did not reached statistical significance. Some covariates related to the patient (age, diabetes, presence of sepsis at ICU admission and urea) or the dialysis treatment (length of dialysis session, net UF, haematocrit, minimum RBV) were also tested in different multivariate model but did not reached statistical significance.
Secondary outcomes
Haemodynamic parameters during haemodialysis. Figure 3 presents the mean haemodynamic parameters plotted against time during the dialysis sessions. Neither SBP ( Figure 3A ) nor diastolic ( Figure 3B ) blood pressure nor heart rate ( Figure 3C ) differed within the course of a dialysis session or among treatment modalities at any time. As presented in Table 4 , the proportion of dialysis sessions with arrhythmia varied from 2.6% in Treatment C to 5.8% in Treatment B without a statistical difference. Furthermore, the proportion of dialysis sessions requiring fluid resuscitation or changes in the vasopressor amount to maintain adequate blood pressure was similar among the three different treatment modalities. Neither the type (e.g. colloid versus crystalloid) nor the administration modality (e.g. through a central venous catheter, a peripheral catheter or the venous blood line of the circuit) of fluid differed significantly among the arms.
Complications during dialysis sessions. The overall rates of catheter dysfunction, filter clotting and dialysis session discontinuation were low, and no statistically significant differences were observed among the three different dialysis therapies (Table 4) . Of note, 40 dialysis sessions (6.7%) required line reversal to complete the treatment, and in these cases, the catheter was removed as soon as possible to allow the next dialysis session.
Discussion
In this single-centre randomized trial with a large number of dialysis treatments, we found no significant difference in intradialytic hypotension rate in ICU patients with AKI requiring IHD when using BV online monitoring alone or combined with active blood temperature control compared with 'standard' hypothermic hypertonic dialysis. Moreover, online monitoring equipment neither modified the intradialytic haemodynamic parameters nor affected the rate of dialysis-related complications.
Our trial was a pragmatic study that included all AKIrelated dialysis sessions with UF. Therefore, it reflected the real-life situation experienced in the department with haemodialysis and has high external validity. Random allocation enhanced the robustness of the results and produced more confidence in their validity compared to previous observational and before-after AKI studies [11, 19, 20] .
The 26.4% rate of hypotension episodes (varying from 29% in controls to 22% in cases) we found in a recent observational before-after study focussing on the same topic [11] was similar to those previously reported in the literature in comparable case-mix populations, ranging from 30% in the Hemodiafe study [21] to 18% in the study of Tonelli et al., which tested the accuracy of BV-controlled UF in acute haemodialysis [20] . All these data led us expect a much greater hypotension rate in our control group than the 17% we observed. The difference between the observed and expected incidence of hypotension may help to explain the non-significant results we obtained in this trial, and the question arises whether the power was sufficient. Despite this, we cannot exclude that, based on a different arbitrary definition of hypotension, a different incidence would have been reported, as recently suggested [20] , we believe that this low incidence of intradialytic hypotension may reflect, at least in part, the clinical practice of an intensivist team experienced with intermittent dialysis therapy respecting guidelines implemented in the ICU to improve intradialytic haemodynamic stability in AKI patients, especially cool dialysate and high sodium conductivity.
The data analysis indirectly provides evidence for good adherence to protocols and internal validity. Indeed, the median Kt/V ID delivered was greater than the prescribed target of 1.2 Kt/V ID . Furthermore, because the minimum RBV was reached in only 4% of the monitored dialysis sessions, UF profiling was effective during the study period, as recently described [11] . We, as other teams [19, 20] , were, however, unable to identify the critical threshold of BV reduction at which hypotension predictably occurs. In addition, isothermal dialysis was also effective in the arm using the BTM® device based on a decrease, despite its small magnitude, in body temperature over the course of the dialysis session compared to the small increase observed during thermoneutral dialysis therapy.
The causes of intradialytic hypotension may be categorized into dialysis-and patient-related factors. Some factors related to the patient on the day of the dialysis session, such as higher SOFA score, the need for vasopressor and lower SBP, were identified as independent predictors of intradialytic hypotension. These expected results are in accordance with the literature [3, 20] , in which the more severely ill the patient, the greater is the risk of symptomatic hypotension. By contrast, we were unable to identify any independent association between hypotension and variables tested related to the dialysis session. For example, it has been shown in chronic haemodialysis by bioimpedance techniques that plasma refilling occurs primarily from peripheral extracellular compartments, especially the legs [22, 23] . This led us to expect a possible correlation between RBV and blood pressure according to the vascular access site. However, dialysis catheter site did not interfere with haemodynamic and cardiovascular reactivity in our prone position AKI critically ill patients. As a possible explanation, all the standard dialysis parameters except for those related to the tested interventions followed current guidelines for RRT in AKI, which dramatically differ from those applied in chronic renal disease dialysis, to achieve optimal intradialytic haemodynamic tolerance in the ICU setting [3] . They were comparable among the arms and were unchanged during the trial period. For example, to improve vascular stability either by lessening plasma osmolality changes or increased vascular peripheral resistance [3, 24, 25] , dialysate sodium conductivity >145 mmol/L was usually applied in the most severe acute patients with unstable haemodynamics in each group.
The main limitation of the study is the small number of patients which may reduce our probability to detect significant differences. The single-centre design may also limit external validity of our results to a broader population [26] . However, the statistical unit, on which the power was computed a priori, was the dialysis session, not the patient. In addition, we provided the baseline characteristics of the cohort studied (Table 1) , which are representative of critically ill patients requiring RRT [27] . We also acknowledge the lack of blinding of the physicians and nursing staff (although a double-blind trial with different dialysis procedures is likely impossible to organize) and the absence of sodium profiling. Indeed, sodium balance-neutral sodium profiling haemodialysis in combination with UF profiling has been associated with intradialytic haemodynamic benefit in chronic dialysis patients [28] and remains to be tested in the ICU setting.
Why did the online BV and blood temperature monitoring, which had been proved effective in other settings [5, 7, 9, [29] [30] [31] , fail to prevent hypotension? Obviously, subjects with AKI requiring IHD in the ICU present different haemodynamic profiles than those chronically dialysed for end-stage renal failure. The basic premise of the use of the RBV is that the blood component remains constant throughout the IHD session and that the variation of the haematocrit is necessarily due to the change in the BV. In critically ill patients, blood flow and peripheral vasomotor tone interact through plasma refilling and cardiovascular reactivity to maintain systemic blood pressure. Moreover, acute disease and dialysis therapy may alter these mechanisms (e.g. haemolysis, blood or capillary leak) and thereby induce intradialytic hypotension via a decrease in absolute or RBV [1] . Consequently, the red blood cell mass or plasma protein density failed to remain constant throughout the length of the session in the ICU and the new dialysis equipment for BV monitoring and modelling and for blood temperature control and biofeedback may not provide similar benefits in critical AKI patients dialysed via central venous catheters.
Further research is needed to improve online BV and temperature monitoring for our critically ills patients. For example, the current BVM system records haematocrit in capillaries which do not exactly reflect the changes occurring in the central venous system, delaying any intervention. Second, this system is based on viscosity. This parameter may not accurately work among patients with low haematocrit and low plasma albumin. Third, there is marked intrapatient variability in response to fluid removal between dialysis sessions, which limits the ability of the biofeedback system. Finally, isothermic dialysis using the BTM takes time and the reduction of temperature is modest.
In conclusion, compared with standard hypothermic hypertonic dialysis therapy, actively controlled body temperature and profiled UF by online monitoring systems did not have a significant impact on the incidence of intradialytic hypotension in unselected critical AKI patients. Therefore, regarding cost consideration, further research is needed before the use of these new sophisticated automatic methods can be applied routinely to our ICU setting.
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